Literature DB >> 34377027

Lateral Ventricular Meningiomas: Clinical Features, Radiological Findings and Long-Term Outcomes.

Haibo Teng1, Zhiyong Liu1, Ouying Yan2, Wenbo He1, Danyang Jie3, Yuanwei Qie4, Jianguo Xu1.   

Abstract

PURPOSE: Lateral ventricle meningioma (LVM) is a rare type of intracranial meningioma, which has been rarely studied. It has different clinical features, imaging features, and long-term results from other locations. This study investigated the epidemiology, clinical characteristics and prognosis of LVM and comprehensively describes its characteristics.
METHODS: This article analyzes the LVMs that were diagnosed pathologically in West China hospital between January 1, 2009 and July 1 2020. Demographic information, imaging characteristics and prognostic factors are discussed. Data analysis was performed using SPSS 23.0 and R version 3.5.3.
RESULTS: We collected 7202 meningiomas and 195 LVMs (136 females; median age, 46 years; range, 5-81 years) were included in this study. Gross total resection was completed in 189 patients. The OS rate was 93.8%, and the recurrence rate was 5.2%. Multivariate regression analysis showed that sex (P = 0.01) and tumor size (P = 0.018) were related to WHO grade. Postoperative KPS (P = 0.003) was associated with OS. WHO grade (P = 0.025), extent of tumor resection (P < 0.001), and hospital day (P=0.028) were associated with recurrence.
CONCLUSION: LVMs require long-term follow-up, individualized treatment, and follow-up strategies to be formulated according to the relevant risk factors.
© 2021 Teng et al.

Entities:  

Keywords:  imaging features; lateral ventricular meningiomas; prognosis; recurrence

Year:  2021        PMID: 34377027      PMCID: PMC8349535          DOI: 10.2147/CMAR.S320651

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


Introduction

Meningioma is the second most common primary tumor of the central nervous system with an annual incidence of 1.5–5.5 per 100,000.1,2 Intraventricular meningiomas (LVMs) are rare tumors that account for 0.5–3% of all intracranial meningiomas.3 Due to sufficient growth space, tumors are often already large when symptoms appear. Although surgical techniques continue to improve, some patients develop postoperative recurrence or metastasis. So far, there have been few reports and studies of LVMs3 and they are incomplete in terms of imaging and clinical data, as well as adequate and relevant risk prediction analyses. It is difficult to obtain tissues for histopathological diagnosis before the surgery; therefore, many LVMs are difficult to diagnose. Compared with other meningioma locations, lateral ventricle meningiomas have different characteristics. Neurologic symptoms typically are more delayed and tumors are quite large at initial diagnosis.4 Partial excision may lead to increased postoperative bleeding.5 Gross total resection is possible through a superior parietal lobule in most LVMs, but a report also showed that the elderly with left side lesion have a greater risk.6 An improved understanding of intraventricular meningiomas can help to diagnosis and apply appropriate treatments. Consequently, we have summarized all cases of LVM undergoing surgery and diagnosed in our hospital in the past 11 years, and conducted detailed statistics and analysis.

Materials and Methods

Subject Selection

This study was approved by the West China hospital Ethics Committee. A total of 7202 patients were histologically confirmed meningioma at the West China Hospital between January 1, 2009 and July 1, 2020 and 195 LVMs were included in the study. Patients were identified by HIS (Hospital Information System). The inclusion criteria for the research are that LVM was confirmed by postoperative pathology and we excluded cases with incomplete clinical information. The tumor sections were reviewed by two expert pathologists and graded histologically according to The 2016 World Health Organization Classification of Tumors of the Central Nervous System. We obtained the following clinical information from HIS including demographic information, clinical features and surgical management. The data of preoperative magnetic resonance imaging (MRI) and the computed tomography (CT) scan were examined via PACS (Picture Archiving and Communication Systems). The Karnofsky Performance Scale (KPS) was used to assess the quality of life. Preoperative and postoperative KPS (pre-KPS and post-KPS) at discharge was evaluated by two authors (Haibo Teng and Zhiyong Liu). Clinic and imaging follow-up examinations were performed at the time of 1, 6, 12 months after surgery. In addition, patients were followed-up by telephone every 1 or 2 years and recorded the KPS scores. Hospital day (HOD) was defined as the number of days between the day of surgery and discharge. In terms of imaging data, tumor size was defined as the largest single dimension recorded from the measurement of the MRI/CT preoperative imaging. Where postoperative imaging was missing or unavailable in the PACS, we relied on the surgeon’s observation based on the operative record to require the extent of resection. After excluding unqualified or missing preoperative imaging data, we collected a total of 118 patients finally. Signal intensity (SI) of the tumor on T1- and T2-weighted and flair MRI was is divided into mixed-intense, hypo-intense, iso-intense and hyper-intense. The shape of tumor was defined base on the solid component appearance and categorized as regular and irregular forms. On T2-weighted imaging, the presence of cerebral edema is judged as a hyperintensity near the tumor. Clear tumor-brain boundary is defined as hypo-intense on T1-weighted imaging and hyperintense on T2-weighted imaging. For the SI on the images of enhancement, the levels were homogeneous enhancement (uniformly enhancing tissue in >90% of the tumor) and heterogeneous enhancement (well-enhanced and less-enhanced portions were mixed). Regarding extent of resection (EOR), we reviewed both the operative records and postoperative MRI imaging reports from each patient. The EOR was categorized as gross total removal (GTR), subtotal removal (STR) based on the comparison of preoperative and postoperative magnetic resonance conditions. We obtained EOR data of 3 patients without postoperative MRI through Surgical Record. Data analysis was performed using SPSS 23.0 and R version 3.5.3.

Result

Patient Population

During the 11 years of study research (2009–2020), a total of 7202 meningioma patients underwent surgical procedures in West China Hospital, including 195 cases (59 male and 136 female) of LVM. The basic information is provided in Table 1. The mean and median follow-up time were 64 (0–143) and 61 months. The mean and median ages of patients were 45 years (range 5–81 years) and 46 years. Eighty-eight patients were on the right side, 96 were on the left side, and 10 were on both sides. Eight patients had received previous tumor-related treatment before enrolment (surgery in 1 patient, radiation in 6 patients and surgery followed by radiation treatment in 2 patients). The median duration of symptoms prior to admission was 60 months (range 0–123), including headache and dizziness (n=122, 68.2%), visual impairment (n=16, 8.2%), movement disorders (n=11, 11.6%), epilepsy (n=11, 11.6%) and others like memory loss, numbness, tinnitus (n=25, 12.8%). Besides this, 10 asymptomatic patients accounted for 5.1% of all patients. The median preoperative KPS score was 90 (range 20–100). Among the entire cohort, 110 patients (56.4%) were pre-KPS scores ≥80 and 85 patients (43.6%) were pre-KPS scores <80. In addition, 12 patients (6.2%) with periprocedural complications were found in the cohort (10 hydrocephalus and 2 cerebral hernia).
Table 1

Patient Characteristics

Value
Median follow-up period, mos (range)61 (0–143)
Median age, yrs (range)46 (5–81)
Sex, F/M136/54
Side, rt/lt/both88/96/10
Mediantumorsize, mm (range)43 (3–120)
Previou streatments9
 Surgery1
 Radiationtherapy6
 Surgery followed by radiation therapy2
Median preop symptom duration, mos (range)60 (0–3700)
Preop symptom
 Headache and dizziness122 (68.2%)
 Visual impairment16 (8.2%)
 Movement disorders11 (11.6%)
 Epilepsy11 (11.6%)
 Others25 (12.8%)
 Asymptomatic10 (5.1%)
Resection
 GTR189
 STR6
Pathology
 WHO grade I145 (74.4%)
 WHO grade II44 (22.5%)
 WHO grade III6 (3.1%)
Radiographic recurrence12 (6.2%)
Treatment after recurrence
 Surgery followed by radiation therapy3
 Radiationtherapy5
 Conservative Treatment4
Patient Characteristics

Radiological and Pathological Characteristics

The radiological information of 118 patients with complete neuroimaging data of all 195 LVM patients in our hospital available are presented in Table 2. The great majority of IVMs had irregular shape (n=87, 73.7%), clear boundary (n=102, 86.4%) and no cystic (n=107, 90.7%). The mean and median tumor size were 46mm and 43mm (range 3–120 mm), with 46 tumors (38.9%) >40 mm and 72 tumors (61.1%) ≤40 mm in diameter. The edema ranged from 0 to 49 mm, with 26 tumors (22.1%) ≥30mm, and 92 tumors (77.9%) <30 mm. The cases of mixed-intense on the T1-weighted (n=44, 37.2%), T2-weighted images (n=77,65.3%) and flair-weighted images (n=80, 67.9%) were observed in the majority of the LVMs (Figure 1). In MRI enhancement sequence, 37 cases (31.4%) were homogenous and 81 cases (68.6%) were heterogeneous. All 195 patients had complete pathological data included for this research. According to the 2016 WHO classification, the pathological results were divided into WHO I grade (n=145,74.4%), WHO II grade (n=44,25.5%) and WHO III grade (n=6, n=3.1%). The univariate analysis of WHO grade was summarized in Table 3. It indicated that sex (P=0.005), tumor size (P=0.02), preoperative KPS (P=0.04), and edema degree (P=0.02) were associated with higher pathological grade. Results of multivariate analyses for association with sex (P=0.01) and tumor size (P=0.018) are shown in Table 3. There was no statistically significant difference (p > 0.05) in all radiological feature including SI and enhancement.
Table 2

The MRI Features in the 118 Cases of LVMs

Value
Tumor size (mm)43 (3–120)
Shape
 Regular31 (26.3%)
 Irregular87 (73.7%)
Boundary
 Clear102 (86.4%)
 Ambiguous16 (13.6%)
 Edema (mm)2 (0–49)
Cystic
 No107 (90.1%)
 Yes11 (10.2%)
T1-weighted
 Mixed44 (37.2%)
 Hypo-10(8.5%)
 Iso-33 (28.0%)
 Hyper-31 (26.3%)
T2-weighted
 Mixed77 (65.3%)
 Hypo-6 (5.1%)
 Iso-13 (11.0%)
 Hyper-22 (18.6%)
Flair–weighted
 Mixed80 (67.9%)
 Hypo-5 (4.2%)
 Iso-7 (5.9%)
 Hyper-26 (22.0%)
Enhancement
 Heterogenous81 (68.6%)
 Homogenous37 (31.4%)
Figure 1

MRI images of typical WHO I (A–D), WHO II (E–H) and WHO III (I–L) of LVM. Most MRI images show mixed-intense and heterogeneous enhancement. Typical low-grade LVM is relatively more regular and clearer boundary, while high-grade LVM has more obvious peritumoral edema and tissue infiltration. Heterogeneous enhancement and perifocal edema in which MRI sequences are indicated by arrows.

Table 3

Univariate and Multivariate Analysis of WHO Grade

Low-GradeHigh-GradePHRP
Sex0.0050.273 (0.102–0.73)0.01
 Male3623
 Famle10927
Tumor size0.025.222 (1.336–20.416)0.02
 ≥40mm6913
 <40mm7030
Age0.91
Pre-KPS0.041.334 (0.484–3.679)0.58
 >808722
 ≤805828
Shape0.18
 Regular274
 Irregular6621
Boundary0.68
 Clear8121
 Ambiguous124
Edema0.051.749 (0.614–4.983)0.30
 ≥30mm179
 <30mm7016
Cystic0.60
 No8522
 Yes83
T1-weighted0.52
 Mixed3212
 Hypo-82
 Iso-267
 Hyper-274
T2-weighted0.30
 Mixed5819
 Hypo-60
 Iso-121
 Hyper-175
Flair–weighted0.64
 Mixed6218
 Hypo-50
 Iso-61
 Hyper-206
Enhancement0.37
 Heterogenous6219
 Homogenous316
The MRI Features in the 118 Cases of LVMs Univariate and Multivariate Analysis of WHO Grade MRI images of typical WHO I (A–D), WHO II (E–H) and WHO III (I–L) of LVM. Most MRI images show mixed-intense and heterogeneous enhancement. Typical low-grade LVM is relatively more regular and clearer boundary, while high-grade LVM has more obvious peritumoral edema and tissue infiltration. Heterogeneous enhancement and perifocal edema in which MRI sequences are indicated by arrows.

Treatment and Long-Term Outcomes

After a median follow-up duration of 46 months (range 0–146 months), the most recent follow-up data were obtained in 186 patients (95.4%) but were lost in 9 patients (4.6%). The overall survival rate of LVMs patients in 11 years was 93.8%. By the end of the follow-up period, twelve patients (6.2%) developed a recurrence following the surgery and 12 patients (6.2%) died. The Kaplan–Meier survival and recurrence curve is shown in Figure 2. The preoperative and postoperative KPS score was no statistically significant difference (P = 0.108) in all patients; however, 86 patients (44.1%) with KPS ≤80 points showed significant improvement of KPS postoperatively (P < 0.01) (Figure 3). In general, most of the patients’ symptoms have improved significantly, and part or all of their life and work can be resumed after the operation. A gross total resection (GTR) was completed in almost all patients (n=189, 97.2%), and a subtotal resection only in 6 patients (2.8%). GTR has better PFS (progression-free survival) than STR. The curve of univariate analysis related to OS and recurrence is shown in Figures 4 and 5. The result of multivariate Cox regression analysis is summarized in Figure 6. Only postoperative KPS (P=0.003) was positively associated with the OS of LVMs in the analysis (HR 9.06, 95% CI: 2.15–38.10). Additionally, the multivariable analyses indicated that the following factors were related to tumor recurrence: WHO grade (P=0.025; HR=4.407; CI: 1.20=16.19), the extent of tumor resection (P < 0.001; HR=0.05; CI: 0.01–0.24) and HOD (hospital day) (P=0.028; HR=4.75; CI: 1.18–19.06).
Figure 2

Kaplan-Meier survival curve illustrates the overall survival, and progression-free survival of 195 LVM patients.

Figure 3

(A) Violin plot illustrating a comparison between the pre- and post-KPS of 85 patients with preoperative KPS score≤80. (B) Violin plot illustrating a comparison between the pre- and post-KPS of all 195 patients.

Figure 4

Kaplan-Meier survival analysis illustrating risk factors for OS. A comparison between the OS based on the WHO grade (A), the tumor size (B), the pre-KPS of patients (C), the extent of edema (D), the gender (E), the MRI enhancement (F).

Figure 5

Kaplan-Meier survival analysis illustrating risk factors for recurrence. A comparison between the OS based on the WHO grade (A), the tumor size (B), the extent of resection (C), the extent of edema (D), the gender (E), the hospital day (F).

Figure 6

The result of multivariate Cox regression analysis. HR for risk of OS (A) and recurrence (B) the blue squares indicate the HR or OR values, and error bars represent 95% CIs.

Kaplan-Meier survival curve illustrates the overall survival, and progression-free survival of 195 LVM patients. (A) Violin plot illustrating a comparison between the pre- and post-KPS of 85 patients with preoperative KPS score≤80. (B) Violin plot illustrating a comparison between the pre- and post-KPS of all 195 patients. Kaplan-Meier survival analysis illustrating risk factors for OS. A comparison between the OS based on the WHO grade (A), the tumor size (B), the pre-KPS of patients (C), the extent of edema (D), the gender (E), the MRI enhancement (F). Kaplan-Meier survival analysis illustrating risk factors for recurrence. A comparison between the OS based on the WHO grade (A), the tumor size (B), the extent of resection (C), the extent of edema (D), the gender (E), the hospital day (F). The result of multivariate Cox regression analysis. HR for risk of OS (A) and recurrence (B) the blue squares indicate the HR or OR values, and error bars represent 95% CIs.

Discussion

Incidence and Clinical Characteristics

LVM is rare, accounting for only 0.5–3% of all meningiomas,7 and has different clinical features and pathological conditions compared to meningiomas in other locations. LVMs are defined as tumors originating from the arachnoid cells in the mesenchymal stroma of the choroid plexus and velum interpositum in the intraventricular location.8,9,10 LVMs are extremely uncommon, resulting in inclusion of a small sample size in previous studies. To the best of our knowledge, our study is the largest case series of LVMs, with the longest follow-up time, in a single center. We systematically reviewed and analyzed the baseline characteristics, neuroimaging features, pathology data, and the survival outcomes, including both relapse and OS of IVMs, to form a more comprehensive understanding of IVMs. In 11 years, 7202 patients with meningiomas were diagnosed in our hospital. LVM accounts for 2.7% (n=195), which is similar to previous reports in the literature. Among 195 cases of LVM, female patients had a higher incidence (F/M=2.3:1), which is similar to previous study.3 The contrasting sex distribution may occur because of a difference in progesterone levels between females and males. However, the proportion of high-grade meningiomas in male patients was higher than in female patients (P=0.005), and the ratio of incidence in males to females for high-grade meningiomas was the same (F/M=1:1). Similar to the meningiomas in other locations, the incidence of LVMs on the left was higher than that on the right side. A specific reason for this difference is not known.10 The age distribution of LVMs is different from that of other meningiomas in general. Previous studies have reported that the age of onset of meningiomas is approximately 60 years.11 Nevertheless, since IVMs are more symptomatic than meningiomas in other locations, we found that the age of onset of LVMs was earlier. The average age of IVMs was 44.9 years, including elderly (34 cases ≥60 years, 17.4%), adults (150 cases, 77.0%), and children (11 cases ≤20 years, 5.6%). Furthermore, unlike meningioma in other locations, the clinical manifestations of LVM are relatively silent, and mild symptoms often last for a long time. Most patients visit the hospital because of persistent headaches or vision problems. This may be due to the anatomy of the lateral ventricle and the mass effect, which also leads to a longer pre-hospital course. Therefore, the tumor usually appears relatively large in volume at the time of LVM diagnosis. The diagnosis of LVM was mainly performed using MRI. Pathological diagnosis remains a gold standard for LVM. The imaging findings and pathological features are presented in Table 2. Kshettry et al have reported that the overall proportion of WHO I, II, and III intracranial meningiomas were 94.6%, 4.2%, and 1.2%, respectively.12 In our cohort, we had a higher proportion of high-grade LVMs, especially WHO grade II (22.5%) tumors. Due to lack of studies on a large population at a global scale, we cannot judge whether the pathological grade is associated with race and region. Our analysis has demonstrated that sex, tumor size, and edema were predictive factors for high-grade LVMs on a univariate analysis (Table 3). We found that high-grade LVMs were larger than WHO grade I. Similar to the findings of previous studies,13–15 edema was found to be a prognostic factor for the pathological grade of meningiomas by univariate analysis. NaKano et al have suggested that the invasive pattern of the tumor-brain interface was related to brain edema of meningiomas.15 Go et al have pointed out that edema fluid flows into the brain tissue from the tumor, following cortical disruption by tumor invasion.13,14 However, this relationship disappeared after controlling for confounders using a multivariate analysis. It has been reported by Whittle et al that meningiomas on MRI are iso- to hypointense on T1-weighted imaging and hyperintense on T2-weighted imaging with strong homogeneous enhancement. Simultaneously, heterogeneous tumor enhancement has been indicated in high-grade meningiomas.16–18 However, there have been no imaging-related studies on LVM in the past. In our cohort, all the T1, T2 and Flair-weighted LVMs in MRI were dominated by mixed-intense. Most enhancement MRI of LVMs, including low-grade LVMs, usually appear as heterogeneous enhancement. In the subsequent analysis, we did not find a significant relationship between MRI signals and WHO grade. This could be due to the duration of LVMs and relatively more free space to expand, eventually unraveling heterogeneous enhancement. High-grade LVMs (n=31) showed a significantly irregular shape compared to low-grade LVMs (n=87), although we found no statistical significance between the tumor shape and WHO grade in the analysis. Lin et al considered that unclear boundary of the tumor was a predictive factor of high-grade meningiomas18 and a feature of aggressive biological behavior.19,20 However, our data revealed no significant relationship between the boundary and grade of LVMs. It is possible that despite the high grade of LVMs, the tumor has ample space to grow before invasion of the surrounding brain tissue, which results in a clear boundary. Therefore, we propose that using imaging features of overall meningiomas to judge the grade of LVMs is not accurate. In the present study, our analysis identified only sex and tumor size as independent predictors to distinguish low- from high-grade LVMs.

Treatment and Prognosis

Similar to the other locations of meningioma, patients with LVMs have good long-term survival. There are two main reasons for the death of LVMs in our study cohort. The first reason is postoperative complications (n=7) within two months after the surgery. The second reason is mainly due to disease progression or non-tumor-related death (n=5). We found that only post-KPS was an independent factor associated with OS of LVMs in the multivariate analysis. Therefore, improvements in surgical techniques are important for the treatment of LVMs. Surgery is still the main mode of treatment for LVMs, and GTR continues to be the primary target of surgery. The rate of GTR in our cohort was 96.9%. STR was chosen mainly because the tumor invaded the surrounding tissues, and to avoid damaging the white matter and causing serious complications. There was no statistically significant difference between pre- and post-KPS in all LVM patients after surgery, in our hospital. This may be due to the large space in the lateral ventricle. In most patients, the tumors were found through mild symptoms; therefore, surgery was performed at an early stage. However, in patients with a KPS≤80, the KPS after the operation was significantly better than that before the operation (P < 0.001). In addition, even WHO grade I LVMs also have a risk of long-term recurrence. Twelve patients (6.2%) in our cohort had relapses. Multivariate analysis showed that WHO classification, EOR (extent of resection), and HOD significantly correlated with recurrence. In 12 cases with recurrence, high-grade LVMs had an absolute advantage (n=8), and the average recurrence time was significantly shorter than that of WHO I LVMs. A high-grade LVM indicates a greater possibility of recurrence, which may be due to pathological parameters related to the aggressiveness of the tumor. Pathological markers such as E-Ca, Ki67, and β-catenin are thought to be related to recurrence.21 Proliferation parameters such as MIB-1 LI have also been proposed to predict the recurrence of meningioma.22–25 Ros-Sanjuan et al advocated that total resection was the only significant factor associated with recurrence,26 and furthermore, Simpson proved that the degree of resection grading system he proposed was related to tumor recurrence.27 However, some scholars believe that the Simpson classification cannot be used as a predictive indicator.28 Voß K et al proved that Simpson grade is not related to the recurrence of intraventricular meningioma.29 Due to the uniqueness of lateral ventricle anatomy and improvements at surgical technique, the GTR rate is higher than the other locations. We found that LVMs still have a high recurrence rate in the cohort (especially high-grade LVMs). The present confirmed that the EOR is related to RFS, EOR alone is not sufficient to predict the recurrence. In some studies, Simpson classification combined with pathological classification was used to predict the recurrence.30 However, in our study, in addition to these two factors, HOD was also a predictor of recurrence. We believe that for patients with longer HOD, the operation is more difficult, and it is more intuitive to consider that the tumor is more aggressive, which may lead to more postoperative complications. Therefore, we believe that a combination of these three factors will be more effective in predicting the recurrence of LVMs. Unterberger et al indicated that surgery + adjuvant radiotherapy (ART) can reduce the recurrence of high-grade meningiomas in their review.31 This is consistent with the results of most studies.32–35 Studies have also shown that the prognosis of patients undergoing ART is worse.36–38 However, there are no randomized controlled trials to prove this. In our cohort, 6 cases of 10 patients who received postoperative radiotherapy had a recurrence. This may be due to higher tumor grade in the patients who chose radiotherapy in our hospital (6 cases of WHO III). Therefore, we cannot prove the correlation between postoperative radiotherapy and recurrence rate.

Limitations

This study has some limitations. First, our study is retrospective, and bias is possible. Second, we lacked complete imaging data for all the LVM patients, which could lead to deviations in statistical analysis. Third, we require multi-center studies and larger samples to obtain more accurate results on the characteristics of LVMs. Fourth, many patients refuse ART, so there are deficiencies in the conclusion of postoperative radiotherapy. Finally, low-grade LVMs require more follow-up time to determine survival and recurrence.

Conclusion

LVM is rare and has different characteristics from other subtypes of meningioma. We conducted the largest single-center retrospective study to date. Our research shows that the age at onset of LVMs is younger, and the course of the disease is more occult. The pathological grade is only related to age and size, and it is unreliable to judge the WHO grade through imaging. Patients with LVMs have a high GTR rate and a good survival rate, but the long-term recurrence rate is still high, especially, for high-grade LVMs. The survival rate is only related to the postoperative KPS, while the recurrence rate is related to the WHO grade, EOR, and HOD. Therefore, individualized treatment and follow-up plans should be developed for patients with LVMs with related high risks.
  38 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection.

Authors:  William C Chen; Stephen T Magill; Dario J Englot; Joe D Baal; Sagar Wagle; Jonathan W Rick; Michael W McDermott
Journal:  Neurosurgery       Date:  2017-08-01       Impact factor: 4.654

Review 3.  Intraventricular meningiomas: a clinicopathological study and review.

Authors:  Harjinder S Bhatoe; Prakash Singh; Vibha Dutta
Journal:  Neurosurg Focus       Date:  2006-03-15       Impact factor: 4.047

Review 4.  Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.

Authors:  Ansley Unterberger; Thien Nguyen; Courtney Duong; Aditya Kondajji; Daniel Kulinich; Isaac Yang
Journal:  J Neurooncol       Date:  2021-02-26       Impact factor: 4.130

5.  Prediction of tumor-brain adhesion in intracranial meningiomas by MR imaging and DSA.

Authors:  Takashi Takeguchi; Hitoshi Miki; Teruhiko Shimizu; Keiichi Kikuchi; Teruhito Mochizuki; Shiro Ohue; Takanori Ohnishi
Journal:  Magn Reson Med Sci       Date:  2003-12-31       Impact factor: 2.471

Review 6.  Meningiomas.

Authors:  Ian R Whittle; Colin Smith; Parthiban Navoo; Donald Collie
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

7.  Meningiomas of the lateral ventricle - a report of 15 cases.

Authors:  G Menon; S Nair; J Sudhir; R Rao; H V Easwer; K Krishnakumar
Journal:  Br J Neurosurg       Date:  2009-06       Impact factor: 1.596

8.  Adjuvant radiotherapy for atypical meningiomas.

Authors:  Hilary P Bagshaw; Lindsay M Burt; Randy L Jensen; Gita Suneja; Cheryl A Palmer; William T Couldwell; Dennis C Shrieve
Journal:  J Neurosurg       Date:  2016-09-09       Impact factor: 5.115

9.  Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.

Authors:  Paulo Henrique Aguiar; Ana Maria Tsanaclis; Oswaldo Inácio Tella; José Pindaro Plese
Journal:  Neurosurg Rev       Date:  2003-04-08       Impact factor: 3.042

10.  Relationship between tumor location, size, and WHO grade in meningioma.

Authors:  Stephen T Magill; Jacob S Young; Ricky Chae; Manish K Aghi; Philip V Theodosopoulos; Michael W McDermott
Journal:  Neurosurg Focus       Date:  2018-04       Impact factor: 4.047

View more
  1 in total

1.  Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series.

Authors:  Lidong Cheng; Hongtao Zhu; Jing Wang; Guanghui Wang; Xiaoyu Ma; Kai Zhao; Junwen Wang; Kai Shu
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.